A Watershed Moment in the Perioperative Treatment of Prostate Cancer

Puntos clave

• Evaluate the effects of perioperative treatments on outcomes in patients undergoing surgery for prostate cancer.
• Randomized trial design with perioperative treatment interventions
• Participants included adult males diagnosed with prostate cancer
• Assessment of clinical and biochemical outcomes after surgical intervention.
• Overall survival improvement with perioperative interventions (HR 0.75, 95% CI 0.60-0.93, p=0.02)
• Biochemical recurrence rates decreased significantly in the treatment group (RR 0.80, 95% CI 0.65-0.95, p=0.01)
• Patient quality of life scores showed enhancement post-treatment, suggesting better management.